Sundhedssektoren dækker alt fra forskning over medicin til sundhedssystemer. Sektoren kan opdeles i to kategorier: “Health Care Equipment and Services” - også kaldet “medico” - og “Pharmaceuticals, Biotechnology & Life Sciences”. Medicoindustrien består af selskaber, der udvikler, producerer og sælger medicinsk udstyr, mens “Pharmaceuticals, Biotechnology & Life Sciences”-kategorien består af store medicinalvirksomheder og biotekvirksomheder, der producerer forskellige former for lægemidler og medicinalvarer. I Danmark har vi en særligt veludviklet medicinalindustri med mange børsnoterede virksomheder, der både er veldrevne og sunde. Sundhedssektoren rummer store investeringsmuligheder, uanset om man er til defensive, langsigtede og sikre selskaber eller de nye og mere risikable selskaber med stort kurspotentiale.
Regnet på de 187 aktier i listen — som percentiler målt mod alle de aktier vi følger, ikke som karakterer. Genberegnes hver dag efter børslukning.
Hvad tallene siger i dag: Kvalitet: lav · Værdi: lav · Momentum: middel — målt som percentiler mod alle de aktier vi følger, ikke som karakterer. Flertallet af aktierne handler over deres egne gennemsnit lige nu. Spændet er stort — kvalitet går fra 0 til 100, så gennemsnittet dækker over meget forskellige selskaber.
| Aktie | Land | Kurs | Ændring |
|---|---|---|---|
| Bavarian Nordic A/S | Danmark | 221,60 | -0,36% |
| H Lundbeck A/S | Danmark | 43,20 | +1,41% |
| H Lundbeck A/S | Danmark | 44,86 | +1,59% |
| Drägerwerk AG & Co. KGaA | Tyskland | 87,60 | +0,23% |
| Orion Oyj | Finland | 81,35 | +0,62% |
| Humana AB (publ) | Sverige | 73,70 | +1,24% |
| Bristol-Myers Squibb Company | USA | 59,59 | 0,00% |
| Attendo AB (publ) | Sverige | 125,60 | -1,34% |
| Amphastar P | USA | 25,91 | +2,13% |
| Getinge AB ser. B | Sverige | 250,60 | +0,28% |
| Ambea AB | Sverige | 175,50 | -0,85% |
| Halozyme Therapeutics, Inc | USA | 109,72 | +1,30% |
| Medtronic plc | USA | 87,09 | -1,00% |
| Demant A/S | Danmark | 324,60 | +1,69% |
| Arjo AB (publ) | Sverige | 26,92 | +0,98% |
| Zealand Pharma A/S | Danmark | 251,10 | -5,46% |
| Novo Nordisk A/S | USA | 37,52 | -0,05% |
| Pfizer Inc | USA | 27,48 | +0,26% |
| Amgen Inc | USA | 402,60 | -0,09% |
| Biogen Inc | Tyskland | 166,36 | +2,98% |
| Roche Holding AG | Schweiz | 321,50 | +0,25% |
| Merck KGaA | Tyskland | 139,00 | +2,17% |
| Synsam AB | Sverige | 53,20 | +2,70% |
| IQVIA Holdings Inc | USA | 259,98 | -0,03% |
| QIAGEN N.V | USA | 45,66 | -0,29% |
| Regeneron Pharmaceuticals, Inc | USA | 737,98 | +1,58% |
| Siemens Healthineers AG | Tyskland | 38,07 | +1,66% |
| InMode Ltd | USA | 13,99 | 0,00% |
| Viatris Inc | USA | 17,58 | -0,26% |
| Ascendis Pharma A/S | USA | 226,05 | -0,87% |
| Humana Inc | USA | 404,27 | +0,05% |
| Novo Nordisk A/S | Danmark | 245,55 | -0,51% |
| Johnson & Johnson | USA | 254,78 | 0,00% |
| Vertex Pharmaceuticals Incorporated | USA | 501,62 | -0,37% |
| AbbVie Inc | USA | 266,69 | +0,35% |
| Henry Schein, Inc | USA | 84,84 | +0,72% |
| Thermo Fisher Scientific Inc | USA | 656,58 | 0,00% |
| Genmab A/S | Danmark | 2.482,00 | +4,42% |
| CellaVision AB | Sverige | 170,60 | +1,67% |
| Centene Corporation | USA | 64,61 | +0,48% |
| Globus Medical, Inc | USA | 76,43 | -0,18% |
| Sanofi ADR | USA | 39,56 | +0,13% |
| argenx SE | Belgien | 834,80 | +2,76% |
| Illumina, Inc | USA | 273,54 | 0,00% |
| Cantargia AB | Sverige | 1,42 | -4,05% |
| Krystal Biotech, Inc | USA | 326,81 | -2,40% |
| DaVita HealthCare Partners Inc | USA | 180,40 | +0,94% |
| Royalty Pharma plc | USA | 56,44 | -0,39% |
| Eli Lilly and Company | USA | 1.157,49 | +1,26% |
| HCA Healthcare, Inc | USA | 432,20 | -0,63% |
| UnitedHealth Group Incorporated | USA | 375,18 | -0,90% |
| ChemoMetec A/S | Danmark | 580,00 | -0,85% |
| Eton Pharmaceuticals, Inc | USA | 54,77 | -1,53% |
| Danaher Corporation | USA | 215,61 | -2,53% |
| AstraZeneca PLC | Sverige | 1.583,50 | +1,51% |
| Novartis AG | USA | 140,79 | 0,00% |
| McKesson Corporation | USA | 921,67 | +0,68% |
| UCB SA | Belgien | 202,30 | +0,70% |
| Camurus AB | Sverige | 637,00 | +0,71% |
| Cardinal Health, Inc | USA | 233,44 | 0,00% |
| BioGaia AB (publ) | Sverige | 114,70 | -0,43% |
| Teva Pharma Industries Ltd ADR | USA | 38,97 | -1,74% |
| Harvard Bioscience, Inc | USA | 8,56 | +0,71% |
| Embla Medical hf | Danmark | 27,65 | +3,75% |
| BeiGene, Ltd. | USA | 364,38 | +0,76% |
| BioPorto A/S | Danmark | 1,08 | +2,37% |
| Swedish Orphan Biovitrum AB (publ) | Sverige | 428,60 | +0,89% |
| Bruker Corporation | USA | 60,66 | -5,01% |
| Abbott Laboratories | USA | 98,16 | -1,94% |
| Sectra AB (publ) | Sverige | 294,60 | -1,01% |
| Boston Scientific Corporation | USA | 42,12 | -0,66% |
| ALK-Abelló A/S | Danmark | 207,00 | +2,27% |
| ICON PLC | USA | 161,69 | 0,00% |
| Almirall, S.A | Spanien | 10,18 | +0,79% |
| Saniona AB | Sverige | 9,30 | -3,02% |
| Tactile Systems Technology, Inc | USA | 22,19 | -1,25% |
| Gilead Sciences, Inc | USA | 144,23 | -0,28% |
| Laboratorios Farmaceuticos Rovi, S.A | Spanien | 58,15 | +1,93% |
| Xeris Pharmaceuticals, Inc | USA | 9,99 | -1,38% |
| BICO Group AB | Sverige | 21,80 | -1,13% |
| Coloplast A/S | Danmark | 418,80 | +2,15% |
| GN Store Nord A/S | Danmark | 107,90 | +0,89% |
| Bonesupport Holding AB | Sverige | 227,20 | -1,47% |
| Alcon Inc | USA | 63,18 | -1,79% |
| Intuitive Surgical, Inc | USA | 404,82 | -0,41% |
| Photocure ASA | Norge | 48,20 | +0,21% |
| Bayer AG NA | Tyskland | 44,44 | +1,09% |
| Ambu A/S | Danmark | 71,00 | +4,11% |
| Swedencare publ AB | Sverige | 21,85 | +0,69% |
| Elekta AB (publ) | Sverige | 53,30 | +0,66% |
| Dynavox Group | Sverige | 74,80 | +1,91% |
| Galmed Pharmaceuticals Ltd | USA | 3,45 | -4,43% |
| Insulet Corporation | USA | 134,73 | -0,66% |
| ArcticZymes Technologies ASA | Norge | 20,10 | -2,43% |
| BioMarin Pharmaceutical Inc | USA | 56,22 | 0,00% |
| Merck & Co., Inc | USA | 141,94 | +1,72% |
| RaySearch Laboratories AB (publ) | Sverige | 183,80 | +0,05% |
| BrainCool AB | Sverige | 1,09 | +3,04% |
| Aurora Cannabis Inc | USA | 4,59 | +2,91% |
| Iovance Biotherapeutics, Inc | USA | 13,02 | -7,99% |
| Novavax, Inc | USA | 11,27 | -10,24% |
| Tempus AI, Inc. Class A Common Stock | USA | 72,64 | -13,06% |
| AbCellera Biologics Inc | USA | 13,15 | -4,57% |
| Sarepta Therapeutics, Inc | USA | 17,31 | -1,03% |
| Cybin Inc. Common Stock | USA | 10,75 | -5,87% |
| Butterfly Network, Inc. | USA | 8,78 | -6,40% |
| Moderna, Inc | USA | 187,70 | -7,63% |
| So-Young International Inc | USA | 2,58 | -6,02% |
| Teladoc Inc | USA | 5,77 | -0,35% |
| Immunitybio Inc | USA | 9,77 | -5,92% |
| Revolution Medicines, Inc | USA | 199,87 | -3,76% |
| Sagimet Biosciences Inc. Series A Common Stock | USA | 8,80 | -2,60% |
| Personalis, Inc | USA | 16,03 | -2,26% |
| Circio Holding ASA | Norge | 11,76 | +4,63% |
| Arcturus Therapeutics Holdings Inc | USA | 13,26 | -9,55% |
| Fate Therapeutics, Inc | USA | 2,29 | -5,76% |
| Alvotech SDB | Sverige | 59,20 | -2,95% |
| Infant Bacterial Therapeutics AB (publ) | Sverige | 69,80 | +1,16% |
| Moberg Pharma AB (publ) | Sverige | 11,22 | +1,45% |
| SoftOx Solutions AS | Norge | 0,13 | +0,31% |
| Mendus AB (publ) | Sverige | 6,05 | -1,63% |
| Recursion Pharmaceuticals, Inc | USA | 4,61 | -3,66% |
| Pharma Equity Group A/S Cl A | Danmark | 0,08 | -6,25% |
| BioArctic AB (publ) | Sverige | 302,20 | +0,33% |
| BioNTech SE | USA | 95,73 | 0,00% |
| CG Oncology Inc. Common stock | USA | 63,43 | -7,68% |
| CRISPR Therapeutics AG | USA | 54,00 | -5,82% |
| Scandinavian Medical Solutions A/S | Danmark | 2,47 | 0,00% |
| Tilray, Inc | USA | 3,78 | +1,61% |
| Dianthus Therapeutics Inc. | USA | 84,11 | -4,46% |
| Pila Pharma AB | Sverige | 1,69 | +1,20% |
| GH RESEARCH PLC DL-025 | Tyskland | 19,40 | -3,00% |
| COMPASS Pathways plc | USA | 11,56 | -0,34% |
| Zomedica Corp. | USA | 0,08 | -5,36% |
| Vitrolife AB | Sverige | 92,70 | +3,40% |
| Canopy Growth Corporation | USA | 0,89 | +0,70% |
| Acrivon Therapeutics Inc. Common Stock | USA | 1,88 | -5,30% |
| Denali Therapeutics Inc | USA | 19,28 | -3,16% |
| Filana Therapeutics, Inc. | USA | 0,87 | 0,00% |
| GH Research PLC | USA | 21,34 | -3,77% |
| Geron Corporation | USA | 1,21 | 0,00% |
| Hansa Biopharma AB | Sverige | 33,84 | +1,87% |
| ExpreS2ion Biotech Holding AB | Sverige | 1,13 | +0,45% |
| Century Therapeutics, Inc. Common Stock | USA | 1,35 | -9,12% |
| Thor Medical ASA | Norge | 4,42 | +0,11% |
| Nano-X Imaging Ltd | USA | 0,62 | -4,29% |
| Editas Medicine, Inc | USA | 2,73 | -2,15% |
| BioInvent International AB | Sverige | 23,05 | +0,66% |
| AC Immune SA | USA | 2,52 | -7,01% |
| StenoCare A/S | Danmark | 0,70 | -17,45% |
| Q linea AB | Sverige | 17,05 | +0,29% |
| Axsome Therapeutics, Inc | USA | 174,34 | -1,55% |
| Fluoguide AS | Sverige | 33,80 | +0,30% |
| Monsenso A/S | Danmark | 0,26 | +4,00% |
| Altimmune, Inc | USA | 2,67 | 0,00% |
| Alzinova AB | Sverige | 0,37 | -2,22% |
| Heron Therapeuti | USA | 0,34 | -9,35% |
| Summit Therapeutics Inc | USA | 17,31 | +0,23% |
| Acarix A/S | Sverige | 0,22 | -1,81% |
| Viking Therapeutics, Inc | USA | 28,39 | -3,04% |
| XSpray Pharma AB | Sverige | 11,18 | +3,71% |
| Co-Diagnostics, Inc | USA | 1,15 | +4,55% |
| Gossamer Bio, Inc | USA | 10,78 | +1,22% |
| Gubra A/S | Danmark | 292,60 | -1,08% |
| Valerio Therapeutics | Frankrig | 0,55 | +8,20% |
| Anavex Life Sciences Corp | USA | 1,60 | -2,74% |
| Corbus Pharmaceuticals Holdings, Inc | USA | 5,78 | -1,20% |
| AIM ImmunoTech Inc | USA | 0,18 | -3,95% |
| Evaxion Biotech A/S | USA | 3,16 | 0,00% |
| ViroGates A/S | Danmark | 8,50 | 0,00% |
| Tenaya Therapeutics Inc. Common Stock | USA | 0,55 | -2,02% |
| Bullfrog AI Holdings, Inc. Common Stock | USA | 0,65 | +9,46% |
| Cardiff Oncology, Inc | USA | 1,07 | -6,14% |
| Sana Biotechnology, Inc | USA | 2,75 | -4,51% |
| Biomea Fusion, Inc | USA | 1,25 | -3,85% |
| Northwest Biotherapeutics, Inc | USA | 0,15 | -1,88% |
| Initiator Pharma A/S | Sverige | 1,87 | -5,09% |
| Lifecare AS | Norge | 0,43 | -6,72% |
| Inovio Pharmaceuticals, Inc | USA | 1,13 | -1,74% |
| Passage Bio, Inc | USA | 4,08 | -0,24% |
| Qlife Holding AB | Sverige | 1,59 | -0,13% |
| Ocugen, Inc | USA | 1,04 | 0,00% |
| 2cureX AB | Sverige | 0,42 | -12,13% |
| Oncopeptides AB | Sverige | 2,05 | -0,39% |
| Xintela AB | Sverige | 0,16 | -5,60% |
| Faron Pharmaceuticals Oy | Finland | 0,41 | +1,36% |
| Aptevo Therapeutics Inc | USA | 1,81 | +0,56% |